Successful salvage therapy with tigecycline after linezolid failure in a liver transplant recipient with MRSA pneumonia
Fuat H. Saner, Matthias Heuer, Peter‐Michael Rath, Julia Gensicke, Arnold Radtke, Nina Drühe, Eva‐Marija Rüngeler, Silvio Nadalin, Massimo Malagó, Christoph E. Broelsch – 20 October 2006 – Pulmonary infections are a significant cause of morbidity and mortality after liver transplantation. Infections with methicillin‐resistant Staphylococcus aureus (MRSA) have increased in the last 10 years. Mortality may exceed 80% in liver transplant recipients who develop MRSA pneumonia.